Company performance
Add to research
Current Price
as of Mar 21, 2025$0.99
P/E Ratio
N/A
Market Cap
$124.89M
Description
Add to research
Nautilus Biotechnology, Inc. is a life sciences company, which engages in the development of a proteomics platform for analyzing and quantifying the human proteome. Its products include Proteome Analysis System, Reagent Kits, and Software and Analysis. The company was founded by Sujal Patel and Parag Mallick in 2016 and is headquartered in Seattle, WA.
Metrics
Add to research
Overview
- HQSeattle, WA
- SectorHealth Technology
- IndustryBiotechnology
- TickerNAUT
- Price$0.99-0.99%
Trading Information
- Market cap$124.89M
- Float45.98%
- Average Daily Volume (1m)163,322
- Average Daily Volume (3m)127,267
- EPS-$0.56
Company
- RevenueN/A
- Rev growth (1yr)N/A
- Net income-$70.78M
- Gross marginN/A
- EBITDA marginN/A
- EBITDA-$75.12M
- EV$111.30M
- EV/RevenueN/A
- P/EN/A
- P/SN/A
- P/B0.60
- Debt/Equity14.60
Documents
Add to research
SEC Filings
Earnings Calls
Factset